SEC Comment Letter for Intersect ENT, Inc. (CIK 0001271214) — Jun 12, 2020
Intersect ENT, Inc. (CIK 0001271214)
Date: June 12, 2020 · CIK: 0001271214 · Accession: 0000000000-20-005227
AI Filing Summary & Sentiment
File numbers found in text: 333-238963
Letter
United States securities and exchange commission logo June 11, 2020 Thomas A. West Chief Executive Officer Intersect ENT, Inc. 1555 Adams Drive Menlo Park, CA 94025 Re:Intersect ENT, Inc. Registration Statement on Form S-3 Filed June 5, 2020 File No. 333-238963 Dear Mr. West: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew B. Hemington, Esq.
Show Raw Text
United States securities and exchange commission logo
June 11, 2020
Thomas A. West
Chief Executive Officer
Intersect ENT, Inc.
1555 Adams Drive
Menlo Park, CA 94025
Re:Intersect ENT, Inc.
Registration Statement on Form S-3
Filed June 5, 2020
File No. 333-238963
Dear Mr. West:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Matthew B. Hemington, Esq.